Citation Impact
Citing Papers
Toll-like receptor 7 (TLR7)–driven accumulation of a novel CD11c+ B-cell population is important for the development of autoimmunity
2011
Interleukin-1 in the pathogenesis and treatment of inflammatory diseases
2011 Standout
Discovery of recurrent t(6;7)(p25.3;q32.3) translocations in ALK-negative anaplastic large cell lymphomas by massively parallel genomic sequencing
2010
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
The 2016 revision of the World Health Organization classification of lymphoid neoplasms
2016 Standout
The Myeloma Drug Lenalidomide Promotes the Cereblon-Dependent Destruction of Ikaros Proteins
2013 StandoutScienceNobel
Chromosomal Rearrangements of 6p25.3 Define a New Subtype of Lymphomatoid Papulosis
2013
Management of Helicobacter pylori infection—the Maastricht IV/ Florence Consensus Report
2012 Standout
Why not treat human cancer with interleukin-1 blockade?
2010
Transcriptional regulation of macrophage polarization: enabling diversity with identity
2011 Standout
Multiple myeloma
2014
Nodal and splenic marginal zone B cell lymphomas
2005
Targeting survivin in cancer therapy: fulfilled promises and open questions
2007
Mutations in the NF-κB signaling pathway: implications for human disease
2006
Lenalidomide downregulates the cell survival factor, interferon regulatory factor‐4, providing a potential mechanistic link for predicting response
2011
The inhibitors of apoptosis (IAPs) as cancer targets
2007
Cell cycle proteins as promising targets in cancer therapy
2017 Standout
Molecular classification of T-cell lymphomas
2009
Sarcoma in the Young Adult Population: An International View
2009
Translocation-Capture Sequencing Reveals the Extent and Nature of Chromosomal Rearrangements in B Lymphocytes
2011
Nodular Lymphocyte Predominant Hodgkin Lymphoma and T Cell/Histiocyte Rich Large B Cell Lymphoma - Endpoints of a Spectrum of One Disease?
2013
IAP-targeted therapies for cancer
2008
Shared Principles in NF-κB Signaling
2008 Standout
Cancer drug resistance: an evolving paradigm
2013 Standout
Reciprocal regulation of the Il9 locus by counteracting activities of transcription factors IRF1 and IRF4
2017 StandoutNobel
NF-κB, the first quarter-century: remarkable progress and outstanding questions
2012 Standout
Incidence of Sarcoma Histotypes and Molecular Subtypes in a Prospective Epidemiological Study with Central Pathology Review and Molecular Testing
2011 Standout
Toll-like Receptors and Their Crosstalk with Other Innate Receptors in Infection and Immunity
2011 Standout
Oncogenes as Novel Targets for Cancer Therapy (Part IV)
2005
Regulation of immunity and oncogenesis by the IRF transcription factor family
2010
AID is required for germinal center–derived lymphomagenesis
2007 StandoutNobel
Network medicine: a network-based approach to human disease
2010 Standout
WHO-EORTC classification for cutaneous lymphomas
2005 Standout
Monoclonal B-cell lymphocytosis (MBL): biology, natural history and clinical management
2010
The complexity of NF-κB signaling in inflammation and cancer
2013 Standout
Morphologic Features of ALK-negative Anaplastic Large Cell Lymphomas With DUSP22 Rearrangements
2015
MYD88 L265P Somatic Mutation in Waldenström's Macroglobulinemia
2012
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
Apoptosis in cancer: from pathogenesis to treatment
2011 Standout
Induction of a Chronic Disease State in Patients With Smoldering or Indolent Multiple Myeloma by Targeting Interleukin 1β-Induced Interleukin 6 Production and the Myeloma Proliferative Component
2009
Antisense therapy for cancer
2005
The JAK/STAT signaling pathway: from bench to clinic
2021 Standout
Targeting apoptosis in cancer therapy
2020 Standout
Clinical characteristics and factors predicting evolution of asymptomatic IgM monoclonal gammopathies and IgM-related disorders
2004
MicroRNA biogenesis pathways in cancer
2015 Standout
Immunity, Inflammation, and Cancer
2010 Standout
Variable frequencies of t(11;18)(q21;q21) in MALT lymphomas of different sites: significant association with CagA strains of H pylori in gastric MALT lymphoma
2003
Cutaneous Manifestations of Lymphoma: A Clinical Guide Based on the WHO Classification
2001
Oncomirs — microRNAs with a role in cancer
2006 Standout
Infectious agents and lymphoma development: molecular and clinical aspects
2009
T(3;14)(p14.1;q32) involving IGH and FOXP1 is a novel recurrent chromosomal aberration in MALT lymphoma
2005
Primary brain tumours in adults
2012 Standout
EGILS consensus report. Gastric extranodal marginal zone B-cell lymphoma of MALT
2011
IgG4-related disease
2014 Standout
Crosstalk in NF-κB signaling pathways
2011 Standout
Transposition of native chromatin for fast and sensitive epigenomic profiling of open chromatin, DNA-binding proteins and nucleosome position
2013 Standout
Primary Cutaneous CD4+ Small/Medium-sized Pleomorphic T-cell Lymphoma Expresses Follicular T-cell Markers
2008
MYC Alterations in Diffuse Large B-Cell Lymphomas
2015
Sex differences in immune responses
2016 Standout
Introduction to NF-κB: players, pathways, perspectives
2006 Standout
The NF- B Family of Transcription Factors and Its Regulation
2009 Standout
Cancer-related inflammation
2008 StandoutNature
The E3 ubiquitin ligase Mib1 regulates Plk4 and centriole biogenesis
2015
Primary Cutaneous Marginal Zone B-Cell Lymphoma
2003
The SYK tyrosine kinase: a crucial player in diverse biological functions
2010
Lyme borreliosis
2011 Standout
Comparative outcomes of rituximab-based systemic therapy and splenectomy in splenic marginal zone lymphoma
2013
Functional Characterization of CFI-400945, a Polo-like Kinase 4 Inhibitor, as a Potential Anticancer Agent
2014
The Roles of Initiating Truncal Mutations in Human Cancers: The Order of Mutations and Tumor Cell Type Matters
2019
Conditional ablation of Ikkb inhibits melanoma tumor development in mice
2010
Primary CNS Lymphoma in Immunocompetent Patients
2009
Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute–Working Group 1996 guidelines
2008 Standout
Pathogen Recognition and Inflammatory Signaling in Innate Immune Defenses
2009 Standout
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration
2015 Standout
Isolation and Characterization of Tumorigenic, Stem-like Neural Precursors from Human Glioblastoma
2004 Standout
Regulation and Function of NF-κB Transcription Factors in the Immune System
2009 Standout
2016 US lymphoid malignancy statistics by World Health Organization subtypes
2016 Standout
A novel Aurora-A kinase inhibitor MLN8237 induces cytotoxicity and cell-cycle arrest in multiple myeloma
2010
A distinctive subtype of t(14;18)-negative nodal follicular non-Hodgkin lymphoma characterized by a predominantly diffuse growth pattern and deletions in the chromosomal region 1p36
2008
Multiple Myeloma
2010
Adult-Type Soft Tissue Sarcomas in Pediatric-Age Patients: Experience at the Istituto Nazionale Tumori in Milan
2005
Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies
2015 Standout
T(14;18)(q32;q21) involving IGH andMALT1 is a frequent chromosomal aberration in MALT lymphoma
2003
Metabolic reprogramming and cancer progression
2020 StandoutScience
Myeloma today: Disease definitions and treatment advances
2015
B7-H1 (PD-L1, CD274) suppresses host immunity in T-cell lymphoproliferative disorders
2009
Fibrohistiocytic Tumors and Related Neoplasms in Children and Adolescents
2012
Prospective Evaluation of Clonal Evolution During Long-Term Follow-Up of Patients With Untreated Early-Stage Chronic Lymphocytic Leukemia
2006
Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes
2015 Standout
Infrequent somatic Fas mutations but no evidence of Bcl10 mutations or t(11;18) in primary cutaneous MALT‐type lymphoma
2003
Emerging Targets in Photopharmacology
2016 StandoutNobel
Enforced expression of Lin28b leads to impaired T-cell development, release of inflammatory cytokines, and peripheral T-cell lymphoma
2012
PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma
2014 Standout
Evolutionary Comparison of the Mechanism of DNA Cleavage with Respect to Immune Diversity and Genomic Instability
2012 StandoutNobel
Multiple Myeloma
2011 Standout
Chemistry and Biology Of Multicomponent Reactions
2012 Standout
Flow cytometric immunophenotyping for hematologic neoplasms
2008
Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems
2012 Standout
E3 ubiquitin ligase Mindbomb 1 facilitates nuclear delivery of adenovirus genomes
2020 StandoutNobel
Works of Ellen D. Remstein being referenced
Del(6)(q22) and BCL6 Rearrangements in Primary CNS Lymphoma Are Indicators of an Aggressive Clinical Course
2008
Recurrent translocations involving the IRF4 oncogene locus in peripheral T-cell lymphomas
2008
Overexpression of Syk tyrosine kinase in peripheral T-cell lymphomas
2008
Adult B-Cell Lymphomas With Burkitt-Like Morphology Are Phenotypically and Genotypically Heterogeneous With Aggressive Clinical Behavior
2005
Splenic small B-cell lymphoma with IGH/BCL3 translocation
2006
Inhibition of survivin expression suppresses the growth of aggressive non-Hodgkin's lymphoma
2004
Expression of CXCL13, a chemokine highly upregulated in germinal center T-helper cells, distinguishes angioimmunoblastic T-cell lymphoma from peripheral T-cell lymphoma, unspecified
2006
Nonrhabdomyosarcoma Soft Tissue Sarcomas in Children
2000
Incidence and Subtype Specificity of API2-MALT1 Fusion Translocations in Extranodal, Nodal, and Splenic Marginal Zone Lymphomas
2000
Primary pulmonary MALT lymphomas show frequent and heterogeneous cytogenetic abnormalities, including aneuploidy and translocations involving API2 and MALT1 and IGH and MALT1
2003
A New Method to Extract Nuclei from Paraffin-Embedded Tissue to Study Lymphomas Using Interphase Fluorescence in Situ Hybridization
2002
Mucosa-Associated Lymphoid Tissue Lymphomas with t(11;18)(q21;q21) and Mucosa-Associated Lymphoid Tissue Lymphomas with Aneuploidy Develop Along Different Pathogenetic Pathways
2002
The Incidence and Anatomic Site Specificity of Chromosomal Translocations in Primary Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue (MALT Lymphoma) in North America
2006
Predictive Value of Blood and Bone Marrow Flow Cytometry in B-Cell Lymphoma Classification: Comparative Analysis of Flow Cytometry and Tissue Biopsy in 252 Patients
2008
Splenic marginal zone lymphoma proposals for a revision of diagnostic, staging and therapeutic criteria
2007
Novel FISH probes designed to detect IGK-MYC and IGL-MYC rearrangements in B-cell lineage malignancy identify a new breakpoint cluster region designated BVR2
2006
Interphase fluorescence in situ hybridization with an IGH probe is important in the evaluation of patients with a clinical diagnosis of chronic lymphocytic leukaemia
2005
Clinical Course and Prognosis of Smoldering (Asymptomatic) Multiple Myeloma
2007
Incidence ofTCRandTCL1Gene Translocations and Isochromosome 7q in Peripheral T-Cell Lymphomas Using Fluorescence In Situ Hybridization
2008
Plexiform Fibrohistiocytic Tumor: Clinicopathologic Analysis of 22 Cases
1999
Strong BCL10 Nuclear Expression Identifies Gastric MALT Lymphomas That Do Not Respond to H. pylori Eradication.
2005
Long-term follow-up of IgM monoclonal gammopathy of undetermined significance
2003
The centrosome index is a powerful prognostic marker in myeloma and identifies a cohort of patients that might benefit from aurora kinase inhibition
2007